InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.670
+0.060 (3.73%)
Apr 28, 2026, 4:00 PM EDT - Market closed
InflaRx Market Cap
InflaRx has a market cap or net worth of $120.73 million as of April 28, 2026. Its market cap has increased by 120.31% in one year.
Market Cap
120.73M
Enterprise Value
67.24M
1-Year Change
120.31%
Ranking
Category
Stock Price
$1.67
Market Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $350.90M to $120.73M, a decrease of -65.59%. That is a compound annual growth rate of -11.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 120.70M | 76.46% |
| Dec 31, 2025 | 68.40M | -52.96% |
| Dec 31, 2024 | 145.40M | 51.46% |
| Dec 29, 2023 | 96.00M | -29.93% |
| Dec 30, 2022 | 137.00M | -34.85% |
| Dec 31, 2021 | 210.30M | 60.17% |
| Dec 31, 2020 | 131.30M | 27.72% |
| Dec 31, 2019 | 102.80M | -88.13% |
| Dec 31, 2018 | 866.00M | 76.55% |
| Dec 29, 2017 | 490.50M | 39.78% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Equillium | 129.61M |
| Innate Pharma | 129.43M |
| Kalaris Therapeutics | 129.20M |
| Edesa Biotech | 126.71M |
| Aardvark Therapeutics | 121.95M |
| Vivani Medical | 115.97M |
| Cardiff Oncology | 114.85M |
| Cognition Therapeutics | 114.37M |